Essa Pharma Inc. (EPIX) NASDAQ
$6.78 0.06 (0.89%)
Market Cap: $297.29M
As of 04/19/24 02:31 PM EDT. Market open.
Essa Pharma Inc. (EPIX)
NASDAQ
$6.78
0.06 (0.89%)
Market Cap: $297.29M
As of 04/19/24 02:31 PM EDT. Market open.
Add to Portfolio
as a clinical-stage pharmaceutical company founded on cutting-edge research, essa is focused on developing novel therapeutics for cancer patients. essa embraces innovation not only in our products but also in our approach. we're firmly rooted in creative and open thinking, giving us an energy and approach that makes us a different kind of pharmaceutical ... read more
as a clinical-stage pharmaceutical company founded on cutting-edge research, essa is focused on developing novel therapeutics for cancer patients. essa embraces innovation not only in our products but also in our approach. we're firmly rooted in creative and open thinking, giving us an energy and approach that makes us a different kind of pharmaceutical company. read less
COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Full Time Employees
17
Address
.
PRICE CHART FOR ESSA PHARMA INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$7.01
Previous Close
$6.72
Days Range
$6.65 - $7.17
52 week range
$2.56 - $11.67
Volume
63,410
Avg. Volume (30 days)
54,313
Market Cap
$297.29M
Dividend Yield
-
P/E
-
Shares Outstanding
44,240,000
Open
$7.01
Previous Close
$6.72
Days Range
$6.65 - $7.17
52 week range
$2.56 - $11.67
Volume
63,410
Avg. Volume (30 days)
54,313
Market Cap
$297.29M
Dividend Yield
-
P/E
-
Shares Outstanding
44,240,000
FINANCIAL STATEMENTS FOR ESSA PHARMA INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR ESSA PHARMA INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Virsik Peter | Chief Operating Officer | Apr 05, 2024 | Sale | $7.94 | 694 | 5,510 | 11,940 | Apr 05, 2024, 06:16 PM |
| Virsik Peter | Chief Operating Officer | Mar 05, 2024 | Sale | $8.98 | 694 | 6,232 | 12,634 | Mar 05, 2024, 06:50 PM |
| Virsik Peter | Chief Operating Officer | Feb 06, 2024 | Option Exercise | $3.23 | 72,782 | 235,086 | 86,110 | Feb 07, 2024, 11:29 AM |
| Virsik Peter | Chief Operating Officer | Feb 06, 2024 | Sale | $10.29 | 72,782 | 748,927 | 13,328 | Feb 07, 2024, 11:29 AM |
| Virsik Peter | Chief Operating Officer | Feb 05, 2024 | Option Exercise | $3.23 | 500 | 1,615 | 13,828 | Feb 06, 2024, 08:27 AM |
| Virsik Peter | Chief Operating Officer | Feb 05, 2024 | Sale | $9.58 | 1,194 | 11,439 | 13,328 | Feb 06, 2024, 08:27 AM |
| Virsik Peter | Chief Operating Officer | Jan 16, 2024 | Option Exercise | $3.23 | 1,718 | 5,549 | 15,740 | Jan 17, 2024, 08:57 PM |
| Virsik Peter | Chief Operating Officer | Jan 16, 2024 | Sale | $10.01 | 1,718 | 17,197 | 14,022 | Jan 17, 2024, 08:57 PM |
| Virsik Peter | Chief Operating Officer | Jan 05, 2024 | Sale | $6.11 | 699 | 4,271 | 14,022 | Jan 08, 2024, 08:06 PM |
| Parkinson David Ross | Chief Executive Officer | Dec 14, 2023 | Buy | $2.30 | 9,223 | 21,213 | 65,675 | Dec 18, 2023, 09:57 PM |
| BERGER FRANKLIN M | Director | Nov 21, 2023 | Buy | $5.73 | 23,259 | 133,274 | 784,404 | Nov 22, 2023, 06:22 PM |
| BERGER FRANKLIN M | Director | Nov 03, 2023 | Buy | $5.99 | 16,471 | 98,661 | 760,875 | Nov 16, 2023, 05:45 PM |
| BERGER FRANKLIN M | Director | Nov 02, 2023 | Buy | $5.35 | 60,000 | 321,000 | 744,404 | Nov 16, 2023, 05:45 PM |
| Parkinson David Ross | Chief Executive Officer | Dec 30, 2022 | Buy | $2.60 | 3,067 | 7,974 | 56,542 | Jan 05, 2023, 06:18 PM |
| Parkinson David Ross | Chief Executive Officer | Dec 22, 2022 | Buy | $2.39 | 21,367 | 51,067 | 53,475 | Jan 05, 2023, 06:18 PM |
| BERGER FRANKLIN M | Director | Dec 14, 2022 | Sale | $3.00 | 25,000 | 75,000 | 932,244 | Jan 05, 2023, 03:41 PM |
| BERGER FRANKLIN M | Director | Dec 21, 2022 | Sale | $2.41 | 72,223 | 174,401 | 718,738 | Jan 05, 2023, 03:41 PM |
| BERGER FRANKLIN M | Director | Dec 20, 2022 | Sale | $2.53 | 43,617 | 110,351 | 756,627 | Jan 05, 2023, 03:41 PM |
| BERGER FRANKLIN M | Director | Dec 16, 2022 | Sale | $2.67 | 50,000 | 133,500 | 800,244 | Jan 05, 2023, 03:41 PM |
| BERGER FRANKLIN M | Director | Dec 15, 2022 | Sale | $2.88 | 82,000 | 235,800 | 900,244 | Jan 05, 2023, 03:41 PM |
| Wood David S. | Chief Financial Officer | Dec 30, 2022 | Buy | $2.60 | 8,302 | 21,585 | 33,343 | Jan 05, 2023, 03:07 PM |
| BIOTECH GROWTH N V | 10% Owner | Oct 27, 2022 | Buy | $4.50 | 500,000 | 2,251,100 | 7,879,583 | Oct 28, 2022, 02:57 PM |
| BIOTECH GROWTH N V | 10% Owner | Oct 26, 2022 | Buy | $3.98 | 1,500,000 | 5,968,500 | 7,379,583 | Oct 28, 2022, 02:57 PM |
| BIOTECH GROWTH N V | 10% Owner | Jul 18, 2022 | Buy | $3.16 | 300,000 | 946,740 | 5,879,583 | Jul 20, 2022, 03:21 PM |
| BIOTECH GROWTH N V | 10% Owner | Jul 14, 2022 | Buy | $2.79 | 347,204 | 969,428 | 5,337,918 | Jul 18, 2022, 12:48 PM |
| BIOTECH GROWTH N V | 10% Owner | Jul 15, 2022 | Buy | $3.13 | 241,665 | 756,798 | 5,579,583 | Jul 18, 2022, 12:48 PM |
| Parkinson David Ross | Chief Executive Officer | Jun 30, 2022 | Buy | $2.96 | 4,887 | 14,456 | 32,108 | Jul 05, 2022, 01:39 PM |
| BIOTECH GROWTH N V | 10% Owner | Apr 27, 2022 | Sale | $5.85 | 25,100 | 146,925 | 4,990,714 | Apr 28, 2022, 12:28 PM |
| BIOTECH GROWTH N V | 10% Owner | Aug 18, 2021 | Buy | $8.88 | 250,000 | 2,218,800 | 5,015,814 | Aug 20, 2021, 12:43 PM |
| BERGER FRANKLIN M | Director | Feb 22, 2021 | Buy | $27.00 | 57,000 | 1,539,000 | 957,244 | Mar 04, 2021, 06:47 PM |
| BERGER FRANKLIN M | Director | Dec 03, 2020 | Option Exercise | $3.64 | 42,207 | 153,701 | 900,244 | Jan 11, 2021, 04:42 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Virsik Peter | Chief Operating Officer | 04/05/2024 | 5,510 |
| Virsik Peter | Chief Operating Officer | 03/05/2024 | 6,232 |
| Virsik Peter | Chief Operating Officer | 02/06/2024 | 235,086 |
| Virsik Peter | Chief Operating Officer | 02/06/2024 | 748,927 |
| Virsik Peter | Chief Operating Officer | 02/05/2024 | 1,615 |
| Virsik Peter | Chief Operating Officer | 02/05/2024 | 11,439 |
| Virsik Peter | Chief Operating Officer | 01/16/2024 | 5,549 |
| Virsik Peter | Chief Operating Officer | 01/16/2024 | 17,197 |
| Virsik Peter | Chief Operating Officer | 01/05/2024 | 4,271 |
| Parkinson David Ross | Chief Executive Officer | 12/14/2023 | 21,213 |
| BERGER FRANKLIN M | Director | 11/21/2023 | 133,274 |
| BERGER FRANKLIN M | Director | 11/03/2023 | 98,661 |
| BERGER FRANKLIN M | Director | 11/02/2023 | 321,000 |
| Parkinson David Ross | Chief Executive Officer | 12/30/2022 | 7,974 |
| Parkinson David Ross | Chief Executive Officer | 12/22/2022 | 51,067 |
| BERGER FRANKLIN M | Director | 12/14/2022 | 75,000 |
| BERGER FRANKLIN M | Director | 12/21/2022 | 174,401 |
| BERGER FRANKLIN M | Director | 12/20/2022 | 110,351 |
| BERGER FRANKLIN M | Director | 12/16/2022 | 133,500 |
| BERGER FRANKLIN M | Director | 12/15/2022 | 235,800 |
| Wood David S. | Chief Financial Officer | 12/30/2022 | 21,585 |
| BIOTECH GROWTH N V | 10% Owner | 10/27/2022 | 2,251,100 |
| BIOTECH GROWTH N V | 10% Owner | 10/26/2022 | 5,968,500 |
| BIOTECH GROWTH N V | 10% Owner | 07/18/2022 | 946,740 |
| BIOTECH GROWTH N V | 10% Owner | 07/14/2022 | 969,428 |
| BIOTECH GROWTH N V | 10% Owner | 07/15/2022 | 756,798 |
| Parkinson David Ross | Chief Executive Officer | 06/30/2022 | 14,456 |
| BIOTECH GROWTH N V | 10% Owner | 04/27/2022 | 146,925 |
| BIOTECH GROWTH N V | 10% Owner | 08/18/2021 | 2,218,800 |
| BERGER FRANKLIN M | Director | 02/22/2021 | 1,539,000 |
| BERGER FRANKLIN M | Director | 12/03/2020 | 153,701 |
Load More Insider Transactions
FUNDS WITH A POSITION IN ESSA PHARMA INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,135,931 | 0.02% | 8.96% | Other |
| D. E. SHAW & CO., INC. | 199,653 | 0.00115% | 18.81% | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 26,858 | 0.00002% | 41.07% | Other |
| RENAISSANCE TECHNOLOGIES LLC | 24,234 | 0.00025% | New | Other |
| BLACKROCK INC. | 7,677 | 0% | No change | Other |
CHANGE IN SHARES OUTSTANDING FOR ESSA PHARMA INC
STOCK BUYBACKS FOR ESSA PHARMA INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
0.07%
1Q
06/30/2023
0.08%
2Q
03/31/2023
0.08%
3Q
12/31/2022
0.13%
4Q
09/30/2022
0.13%
5Q
06/30/2022
0.16%
6Q
03/31/2022
0.22%
7Q
12/31/2021
0.32%
8Q
09/30/2021
2.36%
9Q
06/30/2021
7.59%
10Q
03/31/2021
20.96%
11Q
12/31/2020
32.35%
12Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR ESSA PHARMA INC
LOADING...